Guidelines for the assessment and control of mutagenic impurities in pharmaceuticals
Crossref DOI link: https://doi.org/10.1186/s41021-025-00349-5
Published Online: 2025-12-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Honma, Masamitsu
Text and Data Mining valid from 2025-12-23
Version of Record valid from 2025-12-23
Article History
Received: 25 October 2025
Accepted: 17 December 2025
First Online: 23 December 2025
Declarations
:
: Not applicable.
: The author declares no competing interests.